Safety and Efficacy Study of Vigabatrin to Treat Methamphetamine Dependence
Clinical trial NCT00730522 · TERMINATED
Trial details
- NCT number
- NCT00730522
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-07-01
- Primary completion
- 2009-06-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.